Acurion
Acurion helps oncologists get actionable genomic biomarker information from routine biopsy slides so patients can reach appropriate cancer therapies faster. The company delivers OncoGaze, an AI and machine learning SaaS platform that analyzes digitized histology images to detect molecular features such as homologous recombination deficiency and other clinically relevant biomarkers. OncoGaze integrates with clinical workflows and digital pathology pipelines to accelerate biomarker screening compared with conventional genomic testing. Acurion focuses on precision oncology across tumor types including ovarian, pancreatic, and breast cancer and partners with research and clinical organizations to expand its detection capabilities.
Acurion
Acurion helps oncologists get actionable genomic biomarker information from routine biopsy slides so patients can reach appropriate cancer therapies faster. The company delivers OncoGaze, an AI and machine learning SaaS platform that analyzes digitized histology images to detect molecular features such as homologous recombination deficiency and other clinically relevant biomarkers. OncoGaze integrates with clinical workflows and digital pathology pipelines to accelerate biomarker screening compared with conventional genomic testing. Acurion focuses on precision oncology across tumor types including ovarian, pancreatic, and breast cancer and partners with research and clinical organizations to expand its detection capabilities.